Racket News

Share this post

Did Political and Media Bias Stall the Release of Merck's New Covid-19 Drug?

www.racket.news

Did Political and Media Bias Stall the Release of Merck's New Covid-19 Drug?

Former HHS officials say they tried to accelerate funding for what became Merck's new "miracle" drug last year, but were blocked. How culture-war stupidity may have cost "tens of thousands" of lives

Matt Taibbi
Oct 6, 2021
519
460
Share this post

Did Political and Media Bias Stall the Release of Merck's New Covid-19 Drug?

www.racket.news

It seemed like a rare instance of good news in big doses last week when pharmaceutical giant Merck announced that a new drug called molnupiravir had been shown in tests to cut hospitalizations and deaths by half. The simple, easy-to-take pill would give doctors “a whole new, easy-to-use weapon” in the fight against Covid-19, as the AP put it.

Press observers were ecstatic. Headlines ranged from “Merck pill seen as ‘huge advance’” (Reuters) to “Momentum From Potential Covid-19 Drug Stays Intact” (Yahoo!) to “Everything You Need to Know About Merck’s Game-Changing Covid Pill” (Bloomberg). Nearly every story cited data from Merck’s own press release, which claimed studies had shown an experimental oral drug had tremendous promise. From the Bloomberg article:

Of 385 patients who got the drug, 28 or 7.3% were hospitalized, compared with 53 out of 377 (14.1%) who got a placebo. Through day 29, no deaths were reported in patients who received molnupiravir, but eight died in the placebo arm.

Ev…

Keep reading with a 7-day free trial

Subscribe to Racket News to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Matt Taibbi
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing